Lupin Limited believes it has “the potential to offer significant cost savings” for the UK’s National Health Service after launching the first generic version of Chiesi’s Fostair (beclometasone/formoterol) 100mcg/6mcg dose pressurized metered dose inhaler.
The Indian firm was issued a marketing authorization for its Luforbec branded generic by the UK Medicines and Healthcare products...




